Trademark: 85060357
Status Date
Friday, April 13, 2018
Registration Number
4023649
Registration Date
Tuesday, September 6, 2011
Filing Date
Friday, June 11, 2010
Published for Opposition
Tuesday, November 23, 2010
Cancellation Date
Friday, April 13, 2018
5 Pharmaceutical products and preparations in the form of a suspension intravenously administered to the patients for the treatment of thalassemia and sickle cell anemia, for use in connection with bone marrow transplants
Apr 13, 2018
Cancelled Sec. 8 (6-Yr)
Sep 6, 2011
Registered-Principal Register
Aug 2, 2011
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 1, 2011
Law Office Registration Review Completed
Aug 1, 2011
Allowed Principal Register - Sou Accepted
Jul 26, 2011
Statement Of Use Processing Complete
Jul 15, 2011
Use Amendment Filed
Jul 26, 2011
Case Assigned To Intent To Use Paralegal
Jul 15, 2011
Teas Statement Of Use Received
Jan 18, 2011
Noa E-Mailed - Sou Required From Applicant
Nov 23, 2010
Official Gazette Publication Confirmation E-Mailed
Nov 23, 2010
Published For Opposition
Oct 20, 2010
Law Office Publication Review Completed
Oct 20, 2010
Assigned To Lie
Oct 5, 2010
Approved For Pub - Principal Register
Sep 21, 2010
Assigned To Examiner
Jun 16, 2010
New Application Office Supplied Data Entered In Tram
Jun 15, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
